Forges Partnership with Veritas Genetics to Accelerate Creation of Trusted Marketplace for Genomic Data as a Foundation for Data-Driven Medicine SAN FRANCISCO & BOSTON–Nebula Genomics announced today that it has raised $4.3M million in seed financing with participation from 10 leading venture capital firms. The funds will support the company’s mission to usher in the […]
BOULDER, Colo.–MBio Diagnostics, Inc., a company leading a new era in rapid, on-the-spot clinical diagnostics and sample testing, announced an additional $6 million in Series B financing led by new and existing investors, including MBio’s recently announced strategic veterinary partner, Heska. The funding supports the refinement of the MBio platform and improvements in manufacturing as […]
Recombinetics, a pioneer in gene-editing solutions for human health and animal agriculture, today announced the completion of a $34 million Series A financing round. “We’re pleased to announce the successful completion of our Series A Round,” said Tammy Lee, President and CEO of Recombinetics. “This financing will allow us to accelerate commercialization of this transformative science to […]
NEW YORK — Spheryx, Inc. announced today that the National Science Foundation (NSF) has awarded the company a Phase II-B Small Business Innovation Research (SBIR) grant for $500,000 over 2 years. This new grant is a continuation of an earlier grant entitled “Total Holographic Characterization of Colloids Through Holographic Video Microscopy” and is for the […]
Dundee, UK: Ubiquigent Limited, a company focused on enabling and supporting ubiquitin system targeted drug discovery, announced today that it was awarded a new grant from Innovate UK as part of its Investor Accelerator Pilot to support a project entitled; ‘The development of novel compounds to seed a neurodegeneration drug discovery programme’. The programme provides simultaneous […]
NEWARK, Calif. — Intabio, Inc., announced today the receipt of a Fast Track Small Business Innovation Research (SBIR) grant from the National Center For Advancing Translational Sciences (NCATS) of the National Institutes of Health. The grant will provide $2.3 million in funding for advancing Intabio’s commercial development of Intabio’s Blaze™ system, which utilizes a proprietary microchip technology to separate, […]
Ft. Collins, CO (Fort Collins, CO) – KromaTiD, Inc. announced today that it has been awarded a Fast-Track Small Business Innovation Research (SBIR) grant by the National Human Genome Research Institute. The SBIR program enables scientific excellence and technological innovation by incentivizing small businesses to engage in commercial research and development. This award will fund the […]
BEIJING & CAMBRIDGE, Mass.–EdiGene Inc., which develops genome editing technologies into novel therapeutics for a broad range of diseases and into creative solutions to advance drug discovery, today announced the successful completion of approximately $15 Million in a Series pre-B financing. The financing is led by new investor Lilly Asia Ventures (LAV). New investor Huagai […]
AUSTIN, TEXAS — The Intelligence Advanced Research Projects Activity (IARPA) awarded Signature Science, LLC, a $2.3M contract for the development of the Proteo-ID method. Proteo-ID aims to accurately identify people via protein sequencing from human skin cell samples. The Proteo-ID methodology will significantly expand human forensic analysis through the sequencing of proteins, which are stable […]
SAN DIEGO – Maravai LifeSciences, a leader in providing reagents to researchers, biotherapeutics manufacturers and OEM partners worldwide, announced today that it has completed a new debt financing that was enabled by the company’s strong historical financial performance. In addition to refinancing Maravai’s existing debt at a lower interest rate, the new issuance also provides […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
